Risk factors for chronic thromboembolic pulmonary hypertension - Importance of thyroid disease and function.


Journal

Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377

Informations de publication

Date de publication:
01 2020
Historique:
received: 11 08 2019
revised: 23 10 2019
accepted: 25 10 2019
pubmed: 18 11 2019
medline: 22 6 2021
entrez: 18 11 2019
Statut: ppublish

Résumé

Although a number of risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) have been reported, the exact prevalence is controversial and varies between published cohorts. The aim of the present study was to investigate the prevalence of risk factors in operable CTEPH patients with special emphasis on thyroid disease and function. Overall, 228 CTEPH patients (47.7% female; median age 63 [IQR 52-72] years) scheduled for pulmonary endarterectomy between 01/2014 and 12/2015 were studied. Prevalence of risk factors was assessed, and patients were classified according to their thyroid function based on laboratory measurements. As many as 86.0% of patients reported a history of pulmonary embolism (PE; of those, 24.5% were diagnosed with "acute" PE less than six months before the diagnosis of CTEPH), 80.7% of patients had a blood group non-0 and 24.1% of patients had known thyroid disease (of those, 78.2% hypothyroidism). Laboratory measurements revealed thyroid dysfunction in 10.5% of patients (of those, 54.8% had no known thyroid disease). Patients with hypothyroid function had higher WHO functional classes, NT-proBNP levels and a lower cardiac index compared to patients with euthyroid function. The prevalence of a history of PE and blood group non-0 was higher than previously reported. However, a relevant proportion of patients might have suffered from pre-existing CTEPH rather than acute PE. Thyroid disease and dysfunction were frequent and hypothyroid function associated with more severe disease.

Identifiants

pubmed: 31734602
pii: S0049-3848(19)30470-0
doi: 10.1016/j.thromres.2019.10.025
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-26

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Valentin J Krieg (VJ)

Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Germany.

Lukas Hobohm (L)

Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Center for Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Germany.

Christoph Liebetrau (C)

Department of Cardiology, Kerckhoff Clinic, Bad Nauheim, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Rhine-Main, Germany; Department of Internal Medicine I, Division of Cardiology, University of Giessen, Germany.

Stefan Guth (S)

Department of Thoracic Surgery, Kerckhoff Clinic, Bad Nauheim, Germany.

Sebastian Kölmel (S)

Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Germany.

Christian Troidl (C)

Department of Cardiology, Kerckhoff Clinic, Bad Nauheim, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Rhine-Main, Germany; Department of Internal Medicine I, Division of Cardiology, University of Giessen, Germany.

Eckhard Mayer (E)

Department of Thoracic Surgery, Kerckhoff Clinic, Bad Nauheim, Germany.

Stavros V Konstantinides (SV)

Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece.

Christoph B Wiedenroth (CB)

Department of Thoracic Surgery, Kerckhoff Clinic, Bad Nauheim, Germany.

Mareike Lankeit (M)

Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum (CVK), Charité - University Medicine Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Berlin, Germany. Electronic address: mareike.lankeit@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH